Palonosetron
Back to searchMolecule Structure
Scientific Name
Palonosetron
Description of the Drug
Palonosetron is a serotonin antagonist used in the prophylaxis or management of vomiting that results from emetogenic chemotherapy, and for the management of postoperative nausea and vomiting.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00377
http://www.drugbank.ca/drugs/DB00377
Brand Name(s)
Not Available
Company Owner(s)
Virtus Pharmaceutical Inc, Cipla Ltd, Ingenus Pharmaceuticals Llc, Fresenius Kabi Usa Llc, Sandoz Inc, Sagent Pharmaceuticals Inc, Hospira Inc, Accord Healthcare Inc, Eugia Pharma Specialities Ltd, Dr Reddys Laboratories Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Serotonin 3a (5-HT3a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1899 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3746 | |||
DrugBank | DB00377 | |||
PubChem: Thomson Pharma | 14775945 | 16060983 | ||
PubChem | 6337614 | |||
LINCS | LSM-5266 | |||
Nikkaji | J632.622F | |||
PDBe | O7B | |||
BindingDB | 50417287 | |||
EPA CompTox Dashboard | DTXSID5048342 | |||
DrugCentral | 2046 | |||
ChemicalBook | CB7257940 | CB32131051 | ||
Guide to Pharmacology | 7486 | |||
rxnorm | PALONOSETRON HYDROCHLORIDE | PALONOSETRON | AUROTHIOGLUCOSE | ALOXI |
ChEBI | 85161 | |||
ZINC | ZINC000003795819 |